Trial Profile
Clinical Phase I/IIA Study of Subcutaneous Administration of Ofatumumab in Rheumatoid Arthritis Patients on Stable Dose Methotrexate.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2023
Price :
$35
*
At a glance
- Drugs Ofatumumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 01 Jun 2013 Results published in The Journal of Rheumatology.
- 24 Mar 2012 This trial has been recruiting in France and Spain.
- 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.